First Real-World Experience Administering Etranacogene Dezaparvovec Gene Therapy for People with Hemophilia B

被引：0
|
作者：
Ryan, Matthew L. [1 ]
Miller, Andrea [2 ]
O'Hearn, Patrick [2 ]
Desai, Vidhi Parikh [3 ]
机构：
[1] Green Bay Oncol, Green Bay, WI USA
[2] Hemophilia Outreach Ctr, Green Bay, WI USA
[3] CSL Behring, King Of Prussia, PA USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-190238
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Real-world experience with CFTR modulator therapy
    Tuemmler, Burkhard
    Burgel, Pierre-Regis
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [22] Management of Acquired Hemophilia: A Real-World Experience, 2007-2023
    Thomas, Plate
    Bloomberg, Maya
    Harrington, Thomas
    BLOOD, 2023, 142
  • [23] Designing a study for real-world data on safety and effectiveness of rixubis (Nonacog gamma) in people with hemophilia B
    Tiede, A.
    Klamroth, R.
    Escuriola-Ettingshausen, C.
    Kurnik, K.
    Langer, F.
    Wermes, C.
    Chatterjee, N.
    Rauter, I
    Gringeri, A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 356 - 356
  • [24] Value contribution of etranacogene dezaparvovec gene therapy in moderately severe and severe haemophilia B through multi-criteria decision analysis
    Garcia-Diego, Daniel-Anibal
    Badia, Xavier
    Benitez-Hidalgo, Olga
    Jimenez, Victor
    Juarez, Juan Carlos
    Nunez, Ramiro
    Poveda, Jose Luis
    Trillo, Jose Luis
    Valles, Joan-Antoni
    HAEMOPHILIA, 2024, 30 (06) : 1281 - 1287
  • [25] Real-World Experience Using Emicizumab Prophylaxis for Hemophilia a: Single-Center Experience
    Vagrecha, Anshul
    Stanco, Joseph
    Ulus, Daphenee
    Acharya, Suchitra
    BLOOD, 2020, 136
  • [26] EU gets first hemophilia B gene therapy
    Johnson, Ben
    NATURE BIOTECHNOLOGY, 2023, 41 (04) : 440 - 440
  • [27] EU gets first hemophilia B gene therapy
    Nature Biotechnology, 2023, 41 : 438 - 438
  • [28] Unmet Needs in People with Hemophilia Receiving Prophylaxis Treatment: A Real-World Survey
    Malec, Lynn
    Salehi, Hanna
    Ball, Nathan
    Lai, Sophie
    Afonso, Marion
    BLOOD, 2024, 144 : 2314 - 2315
  • [29] HEALTH-RELATED QUALITY OF LIFE IN THE TWO YEARS FOLLOWING ETRANACOGENE DEZAPARVOVEC GENE THERAPY FOR HAEMOPHILIA B IN THE PHASE 3 HOPE-B TRIAL
    Recht, M.
    Itzler, R. F.
    Miller, J. C.
    Monahan, P. E.
    Pipe, S. W.
    HAEMOPHILIA, 2023, 29 : 114 - 115
  • [30] INTERINDIVIDUAL VARIABILITY OF RESPONSE TO GENE THERAPY IN HAEMOPHILIA B: RANGES OF FACTOR IX INCREASE AFTER 24 MONTHS IN HOPE-B ETRANACOGENE DEZAPARVOVEC TRIAL
    Pipe, S. W.
    Castaman, G.
    Miesbach, W.
    Galante, N.
    Pinachyan, K.
    Le Quellec, S.
    Monahan, P. E.
    HAEMOPHILIA, 2023, 29 : 14 - 14
12345